Cardiac troponin level elevations not related to acute coronary syndromes

Nature Reviews Cardiology

Volumn 10, Issue 11, 2013, Pages 623-634

  Giannitsis, Evangelos ^a   Katus, Hugo A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PATHOPHYSIOLOGY; PERICARDITIS; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN;

ACUTE CORONARY SYNDROME; ANIMALS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HEART DISEASES; HUMANS; MYOCARDIUM; NECROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TROPONIN I; TROPONIN T; UP-REGULATION;

EID: 84886725728     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.129     Document Type: Review

References (109)

1. Katus, H. A. et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am. J. Cardiol. 67, 1360-1367 (1991).
2. Katus, H. A. et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83, 902-912 (1991).
3. Katus, H. A. et al. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J. Mol. Cell. Cardiol. 21, 1349-1353 (1989).
4. Thygesen, K. et al. Third universal definition of myocardial infarction. Nat. Rev. Cardiol. 9, 620-633 (2012).
5. Thygesen, K. et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur. Heart J. 33, 2252-2257 (2012).
6. Giannitsis, E. et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 56, 254-261 (2010).
7. Keller, T. et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361, 868-877 (2009).
8. Reichlin, T. et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361, 858-867 (2009).
9. Hamm, C. W. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 32, 2999-3054 (2011).
10. Hamm, C. W., Giannitsis, E. & Katus, H. A. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 106, 2871-2872 (2002).
11. Jeremias, A. & Gibson, M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann. Intern. Med. 142, 786-791 (2005).
12. Agewall, S., Giannitsis, E., Jernberg, T. & Katus, H. Troponin elevation in coronary vs non-coronary disease. Eur. Heart J. 32, 404-411 (2011).
13. Giannitsis, E. et al. New highly sensitivity assay used to measure cardiac troponin T concentration changes during a continuous 216 km marathon. Clin. Chem. 55, 590-592 (2009).
14. Braunwald, E. et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J. Am. Coll. Cardiol. 36, 970-1062 (2000).
15. Remppis, A. et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 27, 793-803 (1995).
16. Müller-Bardorff, M., Weidtmann, B., Giannitsis, E., Kurowski, V. & Katus, H. A. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin. Chem. 48, 673-675 (2002).
17. Gerhardt, W. et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin. Chem. 37, 1405-1411 (1991).
18. Wu, A. H. & Ford, L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin. Chim. Acta 284, 161-174 (1999).
19. Feng, J., Schaus, B. J., Fallavollita, J. A., Lee, T. C. & Canty, J. M. Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103, 2035-2037 (2001).
20. Feng, Y. J. et al. Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am. J. Clin. Pathol. 110, 70-77 (1998).
21. Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Jarolim, P. & Braunwald, E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur. Heart J. 30, 162-169 (2009).
22. Kurz, K., Giannitsis, E., Zehelein, J. & Katus, H. A. Highly sensitive cardiac troponin T values remain constant after brief exercise-or pharmacologic-induced reversible myocardial ischemia. Clin. Chem. 54, 1234-1238 (2008).
23. Røysland, R. et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin. Sci. (Lond.) 122, 599-606 (2012).
24. Turer, A. T. et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J. Am. Coll. Cardiol. 57, 2398-2405 (2011).
25. th percentile values from a common presumably healthy population. Clin. Chem. 58, 1574-1581 (2012).
26. Saenger, A. K. et al. Multicentre analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412, 748-754 (2011).
27. Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
28. Olivetti, G. et al. Gender differences and aging: effects on the human heart. J. Am. Coll. Cardiol. 26, 1068-1079 (1995).
29. Irfan, A. et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am. J. Med. 125, 491-498 (2012).
30. Hickman, P. E. et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin. Chim. Acta 411, 318-323 (2010).
31. Hessel, M. H. et al. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. 455, 979-986 (2008).
32. Cohn, J. N. et al. Plasma noredrenaline as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819-823 (1984).
33. Swedberg, K., Eneroth, P., Kjekshus, J. & Wilhelmsen, L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS trial study group. Circulation 82, 1730-1736 (1990).
34. Logeart, D. et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am. Heart J. 141, 247-253 (2001).
35. Cheng, W. et al. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96, 2247-2259 (1995).
36. Nunes, J. P. et al. Cardiac troponin I in aortic valve disease. Int. J. Cardiol. 89, 281-285 (2003).
37. Kupari, M., Eriksson, S., Turto, H., Lommi, J. & Pettersson K. Leakage of cardiac troponin I in aortic valve stenosis. J. Intern. Med. 258, 231-237 (2005).
38. Giannitsis, E. et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102, 211-217 (2000).
39. Konstantinides, S. et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106, 1263-1268 (2002).
40. Apple, F. S. & Collinson, P. O. for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin. Chem. 58, 54-61 (2012).
41. Apple, F. S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin. Chem. 55, 1303-1306 (2009).
42. Mueller, M. et al. Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin. Res. Cardiol. 101, 837-845 (2012).
43. Aldous, S. J. et al. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann. Clin. Biochem. 48, 241-248 (2011).
44. Røsjø, H. et al. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. Clin. Chem. 58, 1565-1573 (2012).
45. Reichlin, T. et al. Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am. Heart J. 165, 371-378 (2013).
46. Haaf, P. et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 126, 31-40 (2012).
47. Mueller, M. et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin. Chem. 58, 209-218 (2012).
48. Gassenmaier, T. et al. High-sensitive troponin I in acute cardiac conditions: implications of baseline and sequential measurements for diagnosis of myocardial infarction. Atherosclerosis 222, 116-122 (2012).
49. Keller, T. et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 306, 2684-2693 (2011).
50. Giannitsis, E. et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin. Chem. 56, 642-650 (2010).
51. Reichlin T. et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124, 136-145 (2011).
52. Eggers, K. M., Jaffe, A. S., Venge, P. & Lindahl, B. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain-an evaluation with respect to the Universal Definition of Myocardial Infarction. Clin. Chim. Acta 412, 91-97 (2011).
53. Kavsak, P. A. et al. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin. Chem. 54, 747-751 (2008).
54. Kavsak, P. A., Ko, D. T., Wang, X., MacRae, A. R. & Jaffe, A. S. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin. Chem. 56, 1902-1904 (2010).
55. Aldous, S. J., Richards, A. M., Cullen, L. & Than, M. P. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin. Chem. 57, 1154-1160 (2011).
56. Javed, U. et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am. J. Cardiol. 104, 9-13 (2009).
57. Imazio, M. et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 94, 498-501 (2008).
58. Remes, J., Helin, M., Vaino, P. & Rautio, P. Clinical outcome and left ventricular function 23 years after acute Coxsackie virus myopericarditis. Eur. Heart J. 11, 182-188 (1990).
59. Torbicki, A. et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 29, 2276-2315 (2008).
60. Lankeit, M. et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur. Heart J. 31, 1836-1844 (2010).
61. th et al. Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med. 358, 2117-2126 (2008).
62. Januzzi, J. L. et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur. Heart J. 27, 330-337 (2006).
63. Braga, J. R. et al. Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circ. Heart Fail. 6, 193-202 (2013).
64. Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B. & Wallentin, L. Biomarkers in atrial fibrillation: a clinical review. Eur. Heart J. 34, 1475-1480 (2013).
65. Zellweger, M. J., Schaer, B. A., Cron, T., Pfisterer, M. E. & Oswald, S. Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med. Wkly 133, 439-441 (2003).
66. Redfearn, D. P., Ratib, K., Marshall, H. J. & Griffith, M. J. Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. Int. J. Cardiol. 102, 521-522 (2005).
67. Miranda, R. C., Machado, M. N. & Takakura, I. T. Elevated troponin levels after prolonged tachycardia in patients with normal coronary angiography. Cardiology 106, 10-13 (2006).
68. Schueler, M. et al. Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia. Acute Card. Care 14, 131-137 (2012).
69. Carlberg, D. J., Tsuchitani, S., Barlotta, K. S. & Brady, W. J. Serum troponin testing in patients with paroxysmal supraventricular tachycardia: outcome after ED care. Am. J. Emerg. Med. 29, 545-548 (2011).
70. Chow, G. V. et al. Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine (Baltimore) 89, 141-148 (2010).
71. Hijazi, Z. et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation 125, 1605-1616 (2012).
72. Wallentin, L. C. et al. High sensitivity troponin-T for risk stratification in atrial fibrillation during treatment with apixaban or warfarin [abstract]. Eur. Heart J. 33 (Suppl. 53), P558 (2012).
73. Bugnicourt, J. M. et al. Troponin levels help predict new-onset atrial fibrillation in ischaemic stroke patients: a retrospective study. Eur. Neurol. 63, 24-28 (2010).
74. Wu, A. H. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 27, 959-961 (2001).
75. Altmann, D. R. et al. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS ONE 5, e9017 (2010).
76. Favoury, R. & Neviere, R. Significance and interpretation of elevated troponin in septic patients. Crit. Care 10, 224 (2006).
77. Ammann, P., Fehr, T., Minder, E. I., Günter, C. & Bertel, O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 27, 965-969 (2001).
78. Ammann, P. et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J. Am. Coll. Cardiol. 41, 2004-2009 (2003).
79. Lim, W. et al. Elevated cardiac troponin measurements in critically ill patients. Arch. Intern. Med. 166, 2446-2454 (2006).
80. Bessière, F., Khenifer, S., Dubourg, J., Durieu, I. & Lega, J. C. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med. 39, 1181-1189 (2013).
81. McFalls, E. O. et al. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am. J. Med. 124, 630-635 (2011).
82. Omland, T. et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361, 2538-2547 (2009).
83. Koenig, W. et al. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin. Chem. 58, 1215-1224 (2012).
84. Korosoglou, G. et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 97, 823-831 (2011).
85. Latini, R. et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116, 1242-1249 (2007).
86. Barlera, S. et al. Predictors of mortality in 6, 975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram. Circ. Heart Fail. 6, 31-39 (2013).
87. Nagarajan, V., Hernandez, A. V. & Tang, W. H. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 98, 1778-1786 (2012).
88. Tang, W. H., Wu, Y., Britt, E. B. Jr, Iqbal, N. & Hazen, S. L. Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes mellitus. Diabetes Care 36, 1126-1131 (2013).
89. Everett, B. M. et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 123, 2811-2818 (2011).
90. Hallén, J. et al. Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc. Diabetol. 9, 52 (2010).
91. Lankeit, M. et al. Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 31, 1024-1029 (2008).
92. Filusch, A., Giannitsis, E., Katus, H. A. & Meyer, F. J. High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin. Sci. (Lond.) 119, 207-213 (2010).
93. Apple, F. S., Murakami, M. M., Pearce, L. A. & Herzog, C. A. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106, 2941-2945 (2002).
94. Jacobs, L. H. et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann. Clin. Biochem. 46, 283-290 (2009).
95. McGill, D., Talaulikar, G., Potter, J. M., Koerbin, G. & Hickman, P. E. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin. Chim. Acta 411, 936-939 (2010)
96. deFilippi, C. et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin. Chem. 58, 1342-1351 (2012).
97. Kavsak, P. A., Xu, L., Yusuf, S. & McQueen, M. J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin. Chem. 57, 1146-1153 (2011).
98. de Lemos, J. A. et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304, 2503-2512 (2010).
99. Saunders, J. T. et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123, 1367-1376 (2011).
100. deFilippi, C. R. et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 304, 2494-2502 (2010).
101. Wang, T. J. et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 126, 1596-1604 (2012).
102. de Lemos, J. A. Increasingly sensitive assays for cardiac troponins: a review. JAMA 309, 2262-2269 (2013)
103. deFilippi, C. R. et al. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J. Am. Coll. Cardiol. 60, 2539-2547 (2012).
104. Eggers, K. M. et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur. Heart J. 29, 2252-2258 (2008).
105. Zethelius, B., Johnston, N. & Venge, P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 113, 1071-1078 (2006).
106. Hammarsten, O. et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin. Chem. 58, 628-637 (2012).
107. Reiter, M. et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur. Heart J. 32, 1379-1389 (2011).
108. Normann, J. et al. Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am. Heart J. 164, 698-705 (2012).
109. Scherr, J. et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med. Sci. Sports Exerc. 43, 1819-1827 (2011).